You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for MANNITOL 20%


✉ Email this page to a colleague

« Back to Dashboard


MANNITOL 20%

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Hospira MANNITOL 20% mannitol INJECTABLE;INJECTION 016269 NDA Henry Schein, Inc. 0404-9905-50 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9905-50) / 50 mL in 1 VIAL, SINGLE-DOSE 2022-01-12
Hospira MANNITOL 20% mannitol INJECTABLE;INJECTION 016269 NDA Hospira, Inc. 0409-4031-01 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4031-01) / 50 mL in 1 VIAL, SINGLE-DOSE (0409-4031-16) 2004-11-30
Hospira MANNITOL 20% mannitol INJECTABLE;INJECTION 016269 NDA HF Acquisition Co LLC, DBA HealthFirst 51662-1468-1 50 mL in 1 VIAL, SINGLE-DOSE (51662-1468-1) 2019-12-13
Hospira MANNITOL 20% mannitol INJECTABLE;INJECTION 016269 NDA HF Acquisition Co LLC, DBA HealthFirst 51662-1468-3 25 POUCH in 1 CASE (51662-1468-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1468-2) / 50 mL in 1 VIAL, SINGLE-DOSE 2019-12-13
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Mannitol 20%

Last updated: July 31, 2025

Introduction

Mannitol, a sugar alcohol derived from mannose, serves critical functions in pharmaceutical formulations, notably as an osmotic diuretic, excipient, and stabilizer in various injectable and oral preparations. The 20% Mannitol solution is commonly used in hospitals and laboratories for osmotherapy, cryoprotection, and drug delivery. Securing reliable suppliers for Mannitol 20% demands understanding the global supply landscape, key manufacturers, regional availability, and quality standards to ensure steady procurement aligned with regulatory demands.

Global Market Overview and Demand Drivers

The global demand for Mannitol, including the 20% solution, is driven by its extensive application across medical and pharmaceutical sectors. Its principal uses involve controlling intracranial pressure, kidney function regulation during surgical procedures, and serving as a stabilizing agent in drug formulations [1]. The increased prevalence of neurological disorders and expansion of intravenous therapy protocols further bolster demand.

Key regional markets include North America, Europe, Asia-Pacific, and emerging economies in Latin America and Africa. Asia-Pacific constitutes the largest growth hub owing to manufacturing hubs in China and India, technological advancements, and expanding healthcare infrastructure.

Leading Suppliers and Manufacturers

Several prominent global pharmaceutical ingredient suppliers manufacture Mannitol 20%. Their credibility hinges on consistent quality, compliance with international standards, production capacity, and supply chain robustness.

1. Roquette Frères (France)

Overview: Roquette is a global leader in plant-based ingredients, producing pharmaceutical-grade Mannitol under stringent quality controls. They have a significant market share owing to their advanced manufacturing processes and extensive distribution network.

Capacity & Quality: Their Mannitol USP/EP compliant products meet standards outlined by the U.S. Pharmacopeia and European Pharmacopoeia, ensuring international regulatory acceptance.

2. PAM Perstorp (Sweden)

Overview: PAM Perstorp specializes in manufacturing pharmaceutical excipients, including Mannitol. Their offerings include pharmaceutical-grade Mannitol solutions, with particular focus on purity and biological safety.

Supply Chain: Their global distribution network ensures availability across key markets, with production facilities adhering to Good Manufacturing Practices (GMP).

3. Merck KGaA (Germany)

Overview: Merck supplies pharmaceutical-grade Mannitol, integrating high-quality excipients into their comprehensive portfolio. Their Mannitol is used in parenteral and injectable products.

Standards: Their products comply with USP, EP, and other regulatory standards, facilitating seamless integration into diverse formulations.

4. TEREOS (France)

Overview: TEREOS offers Mannitol solutions tailored for pharmaceutical applications, emphasizing purity and consistency. Their manufacturing leverages biotechnological processes grounded in sustainable practices.

5. Roha Dyechem Pvt Ltd (India)

Overview: An emerging regional supplier specializing in pharmaceutical excipients, including Mannitol. They cater predominantly to the Asia-Pacific markets with cost-effective solutions and reliable supply.

Regional Suppliers and Considerations

Asia-Pacific: This region hosts multiple manufacturers offering Mannitol solutions at competitive prices, primarily in India and China. Companies such as Ming Yuan Pharmaceutical (China) and Srinivasa Phytochemicals (India) are noteworthy.

North America & Europe: Suppliers like Roquette and Merck dominate, focusing on quality assurance and regulatory compliance essential for marketed pharmaceuticals.

Emerging Markets: Suppliers in Latin America and Africa are increasing capacity, often with local partnerships, to meet regional demand.

Quality Standards & Regulatory Compliance

For pharmaceutical applications, Mannitol must meet strict standards, including USP (United States Pharmacopeia), EP (European Pharmacopoeia), and JP (Japanese Pharmacopoeia). Manufacturers must also comply with Good Manufacturing Practices (GMP), ISO certifications, and undergo rigorous quality testing to ensure safety and efficacy.

Supply Chain & Logistics Considerations

Securing a reliable supplier involves evaluating their manufacturing capacity, geographical resilience, inventory management, and transportation capabilities. Disruptions in supply chains, such as during global health crises or regional disruptions, necessitate diversified supplier portfolios.

Long-term contracts, quality consistency, and regulatory documentation (COAs, MSDS, stability data) are critical factors in supplier selection.

Market Trends and Future Outlook

The increasing prevalence of chronic diseases, neurological conditions (e.g., stroke, traumatic brain injury), and advances in sterile injectable formulations are expected to sustain demand for Mannitol 20%. Additionally, innovations in lyophilized or pre-filled forms may influence supplier offerings.

Sustainability considerations are gaining prominence, with many suppliers adopting eco-friendly production processes and sourcing renewable raw materials.

Conclusion

The supply landscape for Mannitol 20% encompasses a mixture of well-established global manufacturers, regional producers, and emerging players. Pharmaceutical companies seeking reliable procurement must prioritize regulatory compliance, quality assurance, and supply chain stability. Strategic diversification of suppliers and ongoing vendor evaluations are vital to mitigate risks associated with supply disruptions.


Key Takeaways

  • Leading global suppliers include Roquette, Merck, PAM Perstorp, and TEREOS, offering high-quality Mannitol 20% solutions compliant with international standards.

  • Regional suppliers in Asia provide cost-effective options but should be evaluated for quality assurance and regulatory acceptance.

  • Regulatory compliance (USP, EP, GMP) is non-negotiable; suppliers must furnish Certificates of Analysis and GMP documentation.

  • Supply chain resilience involves multiple sourcing strategies, inventory management, and considering geopolitical factors.

  • Emerging trends focus on sustainability, formulation innovation, and expanding applications in neurological and surgical therapies.


FAQs

1. What are the primary factors influencing supplier selection for Mannitol 20%?
Regulatory compliance, product quality, manufacturing capacity, supply reliability, cost, and regulatory documentation primarily influence supplier selection.

2. Are regional manufacturers suitable for pharmaceutical-grade Mannitol?
Yes, regional manufacturers can meet quality standards if they adhere to GMP and provide appropriate regulatory documentation. Due diligence is essential.

3. How can I verify a supplier's compliance with international standards?
Request official Certificates of Analysis (COA), GMP certifications, and verify their adherence to USP, EP, or relevant pharmacopoeia standards through audits or third-party assessments.

4. What logistical considerations should be taken into account?
Lead times, transportation infrastructure, storage conditions, geopolitical risks, and contingency planning are crucial to ensure uninterrupted supply.

5. Is there a difference between pharmaceutical-grade Mannitol and other grades?
Yes, pharmaceutical-grade Mannitol complies with strict purity and safety standards (USP, EP), suitable for injectable and medicinal purposes, unlike food or industrial grades.


References

[1] “Mannitol – Pharmaceutical Applications,” International Journal of Pharmacology, 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.